Mar 22 2024 |
The List Grows: Kentucky Lawmakers Close in on Comprehensive Privacy Law |
McDermott Will & Schulte LLP |
Mar 21 2024 |
EPA Issues Draft Risk Evaluation for Formaldehyde, Preliminarily Finds That Formaldehyde Poses Unreasonable Risk to Human Health |
Bergeson & Campbell, P.C. |
Mar 21 2024 |
FDA Announces End of PFAS Use in US Food Packaging |
Squire Patton Boggs (US) LLP |
Mar 21 2024 |
Revised OCR Guidance Provides New Examples, but Raises More Questions, Regarding Use of Online Tracking Technologies by HIPAA Covered Entities and Business Associates |
Epstein Becker & Green, P.C. |
Mar 21 2024 |
House Passed New Bill to Prohibit Data Brokers from Transfering Sensitive Data to Foreign Adversaries |
Troutman Amin, LLP |
Mar 21 2024 |
UK’s Financial Conduct Authority Publishes Business Plan |
Cadwalader, Wickersham & Taft LLP |
Mar 21 2024 |
Convergent Outsourcing Settles Data Breach Class Action for $2.45 Million |
Robinson & Cole LLP |
Mar 21 2024 |
President Biden Issues Executive Order Restricting Bulk Transfers of Sensitive Personal and US Government-Related Data |
K&L Gates LLP |
Mar 21 2024 |
California Privacy Protection Agency’s Regulations on Automated Decision-Making Technology, Risk Assessments Delayed |
Robinson & Cole LLP |
Mar 21 2024 |
FDA Publishes Paper Detailing Actions It Intends to Take Regarding the Uses of AI Across the Medical Product Life Cycle |
Nelson Mullins |
Mar 21 2024 |
Privacy Tip #392 – Legitimate Platforms and AI Used to Bypass MFA |
Robinson & Cole LLP |
Mar 21 2024 |
CHEAP STUFF, EXPENSIVE LAWSUIT: TEMU Loses Big in Effort to Compel OTSA Class Action to Arbitration |
Troutman Amin, LLP |
Mar 21 2024 |
New Hampshire Enacts a Comprehensive Privacy Law |
Katten |
Mar 21 2024 |
Utah Law Makes AI Subject to Consumer Protection Laws |
Nelson Mullins |
Mar 21 2024 |
Document Review Protocols for Mass Tort and Product Liability Cases |
Greenberg Traurig, LLP |
Mar 20 2024 |
2024 Litigation Look Ahead Series: Key Cases That Could Impact CERCLA Liability and Contribution Claims |
Beveridge & Diamond PC |
Mar 20 2024 |
Class Action Year in Review: Biometric Privacy |
ArentFox Schiff LLP |
Mar 20 2024 |
Class Action Year in Review: Wiretapping Update From Class Action to Mass Arbitration |
ArentFox Schiff LLP |
Mar 20 2024 |
EU Cracks Down on Environmental Claims |
Beveridge & Diamond PC |
Mar 19 2024 |
The Joint Commission’s National Patient Safety Goal: Advancing Health Equity |
Polsinelli PC |
Mar 19 2024 |
Artificial Intelligence’s Role in Reshaping Behavioral Health and Navigation of Legal Risks Ahead |
Polsinelli PC |
Mar 19 2024 |
Nevada Rejects Patient’s Effort to Create New PSQIA Privilege Waiver |
Wilson Elser Moskowitz Edelman & Dicker LLP |
Mar 19 2024 |
The Countdown to Complete Your Consumer Health Data Privacy Policy Under the Washington My Health My Data Act |
K&L Gates LLP |
Mar 19 2024 |
Food Industry Group Files Brief in Support of GMO Labeling Rule |
Keller and Heckman LLP |
Mar 18 2024 |
The Landscape of GIPA Litigation in Illinois |
Sheppard, Mullin, Richter & Hampton LLP |
Mar 18 2024 |
Global AI Regulation: Europe Takes Momentous Action To Manage AI |
Barnes & Thornburg LLP |
Mar 18 2024 |
Telemarketing Sales Rule Changes Remove Exception for Business-to-Business Calls and Impose New Recordkeeping Requirements |
Hunton Andrews Kurth |
Mar 18 2024 |
ECHA Clarifies Next Steps for PFAS Restriction Proposal |
Bergeson & Campbell, P.C. |
Mar 15 2024 |
February 2024 Bounty Hunter Plaintiff Claims |
Keller and Heckman LLP |
Mar 15 2024 |
A New Regulatory Landscape for Consumer Products Containing Button Cell or Coin Batteries |
Foley & Lardner LLP |
Mar 15 2024 |
RAW DOG: Bottom Line Concepts Stuck in TCPA Class Action Over Snoop Dogg “Approved” Message |
Troutman Amin, LLP |
Mar 14 2024 |
Biden Budget Proposal Advances AI Priorities |
Squire Patton Boggs (US) LLP |
Mar 14 2024 |
FTC Sending Out Refunds in “Review Hijacking” Case |
Troutman Amin, LLP |
Mar 14 2024 |
Clinical Research: FDA Issues Draft Guidance on Informed Consent |
Foley & Lardner LLP |
Mar 14 2024 |
HHS Announces 42 Part 2 Final Rule to Align with HIPAA |
Sheppard, Mullin, Richter & Hampton LLP |